Correction to: Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials (Clinical Drug Investigation, (2019), 39, 5, (421-428), 10.1007/s40261-019-00765-w)

Research output: Contribution to journalComment/debate

Abstract

The original version of this article unfortunately contained a mistake. The corresponding author was incorrect.

Original languageEnglish
Number of pages1
JournalClinical Drug Investigation
Volume39
Issue number7
DOIs
Publication statusPublished - 2019 Jul 1

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Correction to: Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials (Clinical Drug Investigation, (2019), 39, 5, (421-428), 10.1007/s40261-019-00765-w)'. Together they form a unique fingerprint.

  • Cite this